My work at the Vanderbilt ALS Research Center aligns closely with VALIANT’s mission to advance AI through interdisciplinary collaboration and innovation. Our research integrates advanced computational biology, multi-omics data, and AI-driven modeling to uncover mechanisms of ALS and identify therapeutic targets. We’re leveraging machine learning tools to analyze complex genetic and epigenetic datasets, develop predictive models of disease progression, and design personalized approaches to treatment. This work thrives on cross-disciplinary synergy-bringing together neuroscience, data science, and clinical insight-which mirrors VALIANT’s commitment to dissolving academic silos. Our goals of building scalable, impactful research platforms and translating discoveries into real-world outcomes strongly resonate with VALIANT’s vision for agile innovation and strategic investment.